Analyst predicts that covid-19 will still affect Demant

On Tuesday morning, Demant will present its interim management statement for Q1, in which it is expected that corona will play a significant role. The firm will also report on the reception of Oticon More.
Demant CEO Søren Nielsen | Photo: Kenneth Lysbjerg Koustrup/ERH
Demant CEO Søren Nielsen | Photo: Kenneth Lysbjerg Koustrup/ERH
BY RITZAU FINANS, TRANSLATED BY NIELSINE NIELSEN

Covid-19, increasing infection rates and restrictions in many markets will keep being significant in Danish hearing aid firm Demant's communication when the firm presents its interim management statement for Q1 early on Tuesday.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading